Crossmark

Non-invasive prenatal testing of fetal chromosomal aneuploidies: validation and clinical performance of the veracity test

Crossref DOI link: https://doi.org/10.1186/S13039-019-0446-0

Published: 2019-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Kypri, Elena

Ioannides, Marios

Touvana, Evi

Neophytou, Ioanna

Mina, Petros

Velissariou, Voula

Vittas, Spiros

Santana, Alfredo

Alexidis, Filippos

Tsangaras, Kyriakos

Achilleos, Achilleas

Patsalis, Philippos

Koumbaris, George
License Information

Text and Data Mining valid from 2019-07-15
More Information

Article History

Received: 7 May 2019

Accepted: 30 June 2019

First Online: 15 July 2019

Ethics approval and consent to participate

: The study was approved by National Bioethics Committee and all participants provided a written informed consent prior to participation.

: Not Applicable

: EK, MI, ET, IN, VV, KT, AA, PP, GK are employed by NIPD Genetics Public Company Ltd. PM was employed by NIPD Genetics Public Company Ltd. at the time of the study but currently has no conflict of interest. SV, AS, FA have no conflict of interest.